Prevalence of Candida spp., xerostomia, and hyposalivation in oral lichen planus - A controlled study

Carregando...
Imagem de Miniatura
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
ORAL DISEASES, v.20, n.3, p.e36-e41, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To determine the frequency of Candida spp., xerostomia, and salivary flow rate (SFR) in three different groups: patients with OLP (OLP group), patients with oral mucosal lesions other than OLP (non-OLP group), and subjects without oral mucosal lesions (control group). Material and methods Xerostomia as well as SFR was investigated in the three groups. Samples for isolation of Candida spp. were collected from OLP lesions (38 patients), non-OLP lesions (28 patients), and healthy subjects (32 subjects). Results There was no statistically significant difference regarding the frequency of xerostomia and hyposalivation among the three groups (P>0.05). A higher prevalence for colonization by Candida spp. was found in the healthy subject as compared to that of patients with OLP (P=0.03) and non-OLP (P=0.02) groups. Low SFR was not a factor for colonization by Candida spp. Conclusions Xerostomia and hyposalivation occur with similar frequency in subjects with and without oral lesions; also, the presence of oral lesions does not increase the susceptibility to colonization by Candida spp. It seems that any study implicating Candida spp. in the malignant transformation of oral lesions should be carried out mostly on a biochemical basis, that is, by testing the capability of Candida spp. to produce carcinogenic enzyme.
Palavras-chave
diagnoses, xerostomia, oral, oral cancer, hyposalivation, oral lichen planus, Candida
Referências
  1. Axell T, 1996, J ORAL PATHOL MED, V25, P49, DOI 10.1111/j.1600-0714.1996.tb00191.x
  2. Bergdahl M, 2000, J DENT RES, V79, P1652
  3. Billings RJ, 1996, COMMUNITY DENT ORAL, V24, P312, DOI 10.1111/j.1600-0528.1996.tb00868.x
  4. Campanha NH, 2005, ORAL DIS, V11, P392, DOI 10.1111/j.1601-0825.2005.01135.x
  5. Carbone M, 2009, ORAL DIS, V15, P235, DOI 10.1111/j.1601-0825.2009.01516.x
  6. Colquhoun AN, 2004, ORAL SURG ORAL MED O, V98, P60, DOI 10.1016/j.tripleo.2003.11.003
  7. GAINZACIRAUQUI ML, 2012, J ORAL PATHOL MED, V42, P243
  8. Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61
  9. Hirota SK, 2011, MED ORAL PATOL ORAL, V16, pE750, DOI 10.4317/medoral.17095
  10. Kleinegger CL, 2001, ORAL SURG ORAL MED O, V92, P62, DOI 10.1067/moe.2001.115973
  11. Lipperheide V, 1996, MYCOPATHOLOGIA, V134, P75, DOI 10.1007/BF00436868
  12. Lodi G, 2005, ORAL SURG ORAL MED O, V100, P164, DOI 10.1016/j.tripleo.2004.06.076
  13. Masaki M, 2011, MICROBIOL IMMUNOL, V55, P66, DOI 10.1111/j.1348-0421.2010.00285.x
  14. NAVAZESH M, 1995, ORAL SURG ORAL MED O, V80, P284, DOI 10.1016/S1079-2104(05)80384-1
  15. Pincus DH, 2007, MED MYCOL, V45, P97, DOI 10.1080/13693780601059936
  16. Porter SR, 2004, ORAL SURG ORAL MED O, V97, P28, DOI 10.1016/j.tripleo.2003.07.010
  17. SCREEBNY L, 2000, INT DENT J, V50, P140
  18. SCULLY C, 1994, CRIT REV ORAL BIOL M, V5, P125
  19. Torres SR, 2002, ORAL SURG ORAL MED O, V93, P149, DOI 10.1067/moe.2002.119738
  20. van der Meij EH, 2003, J ORAL PATHOL MED, V32, P507, DOI 10.1034/j.1600-0714.2003.00125.x
  21. van der Meij EH, 2007, ORAL ONCOL, V43, P742, DOI 10.1016/j.oraloncology.2006.09.006
  22. Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
  23. Zeng X, 2009, MYCOSES, V52, P161, DOI 10.1111/j.1439-0507.2008.01554.x